News & Events

StageBio Welcomes Senior Pathologist: Dr. Suresh Muthupalani

It is with great honor that we introduce Dr. Suresh Muthupalani as a Senior Pathologist at StageBio. We are happy to have him on the team and look forward to all he will accomplish!

As part of our pathologist team, Dr. Muthupalani will support StageBio’s mission by:

  • Serving as subject matter expert and senior pathologist for preclinical studies supporting the development of therapeutic antibodies and related biologics
  • Dynamically foster productive collaborations with clients

“We are thrilled and proud that Dr. Suresh Muthupalani is joining the StageBio team. His vast experience and expertise in veterinary anatomic pathology as well as his research in pathology studies including cancer, inflammation, infectious disease, and nanotechnology constitute a strengthening of our team and equip us for a brighter future. We look forward to his contributions and all he will accomplish,” says Kathy Bailey, Vice President, Specialty Operations at StageBio.

StageBio is committed to our mission of improving lives through high-quality histopathology, diagnostics and research. Join us in welcoming Dr. Suresh Muthupalani as part of this mission!

The StageBio team is growing! If you are interested in learning more about our current open positions, please visit our careers page here.

About Suresh Muthupalani, BVSc, MVSc, PhD, DACVP

Dr. Suresh Muthupalani brings over 10 years of experience in the field of veterinary anatomic pathology, working with a variety of laboratory animal species and focusing on animal models of disease. Dr. Muthupalani completed his veterinary anatomic pathology training at the Tufts Cummings School of Veterinary Medicine disease and is a Diplomate of the American College of Veterinary Pathologists (ACVP). Dr. Muthupalani pursued his graduate training in Microbiology and obtained his PhD from the University of Kentucky. He completed his professional veterinary degree and master’s degree in Veterinary Pathology in India. Prior to joining StageBio, Dr. Muthupalani served as a comparative pathologist and Assistant Director in the Division of Comparative Medicine, Massachusetts Institute of Technology, for more than a decade, where he conducted independent and collaborative research pathology studies in diverse areas including cancer, inflammation, infectious disease, nanotechnology, spontaneous disease using various animal models. At MIT, he directed the histology and diagnostic labs and actively trained numerous laboratory animal and veterinary pathology fellows. Over the course of his career, Dr. Muthupalani has provided his pathology expertise to numerous investigators, postdoctoral fellows and graduate/undergraduate and holds 80+ publications to his credit.

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com.

Back to Index

Upcoming Events

ASGCT (American Society of Gene and Cell Therapy)

May 16-19, 2022, Walter E. Washington Convention Center, Washington, D.C.

Society of French Pathology Toxicology

May 19-20, Toulouse, France
Listen to our presentation by Dr. Serge Rousselle, CSO, on the scientific value of histopathological evaluation during the nonclinical safety assessment of medical devices

Popular Posts

Learn more about StageBio’s COVID-19 response